Coaching for Performance Improvement in Opioid Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help addiction treatment clinics enhance care for individuals with opioid use disorder. It will test a new approach, called metrics-driven quality improvement (MDQI), which includes training staff to use data effectively, focusing on patient-centered care, and employing digital tools to track patient progress. The goal is to enable clinics to use medications more effectively, retain patients in treatment longer, and support more individuals in achieving recovery. Clinics in the New York area with at least 50 clients per year, along with all their staff and patients, are ideal participants. As an unphased trial, this study offers patients the chance to contribute to innovative improvements in addiction treatment practices.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving treatment in clinics, so it's best to ask the trial organizers for more details.
What prior data suggests that this facilitation model is safe for addictions treatment clinics?
Research has shown that the metrics-driven quality improvement (MDQI) approach helps addiction clinics use medicines for opioid use disorder (OUD) more effectively and improve patient care. Studies have found that these strategies can increase the use of medications for OUD and help patients remain in treatment longer. This approach enhances current treatment methods rather than introducing new, untested medications.
Since this approach targets clinic processes instead of direct patient treatments, participants face no major safety concerns. The MDQI intervention involves training, guidance, and electronic tools to make care more patient-centered and effective. It focuses on improving clinic operations, which generally poses minimal risk to individuals.
Overall, evidence suggests that the MDQI intervention is safe for participants. It supports clinics and improves patient outcomes without introducing direct medical risks.12345Why are researchers excited about this trial?
Researchers are excited about metrics-driven quality improvement (MDQI) for opioid use disorder because it offers a fresh approach to enhancing treatment outcomes by focusing on performance improvement. Unlike traditional treatments that primarily rely on medication like methadone or buprenorphine, MDQI emphasizes systematic evaluation and enhancement of care practices, which could lead to more personalized and effective treatment strategies. This approach could transform how healthcare providers address opioid use disorder by continuously refining their methods based on data-driven insights, potentially leading to better patient results and more efficient use of resources.
What evidence suggests that the metrics-driven quality improvement intervention is effective for opioid use disorder?
This trial will compare a Metrics-driven quality improvement (MDQI) intervention with a control group. Research has shown that data and coaching can enhance addiction treatment. For instance, studies have found that medications like buprenorphine reduce the risk of death by 66% to 80% in patients with opioid use disorder (OUD). The MDQI approach aims to help clinics improve care by increasing the use of these effective treatments. It emphasizes personalized care and tracks patient progress with electronic tools. These strategies aim to retain patients in treatment longer, potentially leading to better recovery outcomes.26789
Who Is on the Research Team?
Charles Neighbors, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for substance use disorder clinics near New York City and the Capital Region with at least 50 clients yearly. It includes staff and patients on Medicaid, not co-insured with Medicare, from these clinics. Clinics with fewer than 50 annual clients are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Clinics receive training on data-driven management, patient-centered care, and use of electronic tools for shared decision making and patient progress monitoring
Follow-up
Participants are monitored for changes in health status, retention in care, and other secondary outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Metrics-driven quality improvement (MDQI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
New York State Office of Addiction Services and Supports
Collaborator
UConn Health
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator